IP footprint
The TLO is entrusted with managing IP for numerous SFU innovators in a diverse number of industry sectors.
1300+
IP Assets under TLO management
$1.5M
licensing revenue in last 12 months
7+
startups formed in last 12 months
Innovation within the SFU ecosystem
Much of the innovation happening within the SFU ecosystem is taking place in the following sectors: clean tech, electronics, life sciences and medical devices.
![](/content/dam/sfu/technology-licensing/IPFootprint/allsectors SK.jpg/jcr:content/renditions/large.jpg)
This chart represents the diversity of the TLO IP portfolio with respect to major industry sectors.
![](/content/dam/sfu/technology-licensing/IPFootprint/Lifesciences sector SK.jpg/jcr:content/renditions/large.jpg)
British Columbia has the fastest-growing life sciences sector in Canada. TLO is supporting a wide Life Sciences portfolio including: 1. Dual-Action EP4 Agonist—Bisphosphonate Conjugates (Robert Young); 2. Reagents for Synthesizing Nucleosides (Robert Britton); and 3. Selective glcosidase inhibitors and uses thereof (David Vocadlo).
![](/content/dam/sfu/technology-licensing/IPFootprint/Electronics Sectors SK.jpg/jcr:content/renditions/large.jpg)
The TLO's IP portfolio within the Electronics sector embodies pioneering innovation that is shaping the trajectory of future technology. These technologies include: 1. Magnetic Coupling Layers STT-RAM (Erol Girt); 2. Hyperjump - VR Navigation Solution (Bernhard Riecke); and 3. Yagiz Aksoy – AI Intrinsic Image Decomposition via Ordinal Shading (Yagiz Aksoy).
![](/content/dam/sfu/technology-licensing/IPFootprint/CleanTech Sectors SK.jpg/jcr:content/renditions/large.jpg)
TLO has made cleantech one of its innovation priorities, and is home to world-leading translational researchers Included within the TLO’s cleantech portfolio are: 1. Hydrogen Electrolyzer AEM/PEM membranes (Steven Holdcroft); 2. Hydrogen Embrittlement Resistant Coating technology (Sami Khan); and 3. Honey Bee Varroa Mite Acaricides (Erika Plettner).
![](/content/dam/sfu/technology-licensing/IPFootprint/Medical Devices sectors SK.jpg/jcr:content/renditions/large.jpg)
TLO is actively fostering innovation within its Medical Devices portfolio, envisioning a transformed approach to patient care and striving for a healthier future. Portfolio includes: 1. Ultrasensitive and Rapid Cytokine Diode Sensor Based on Asymmetric 2D crystals for Health Applications (Michael Adachi) and 2. Electrical Sensor and Blood Pressure Monitoring System (Woo Soo Kim).